Why the study?
Does chlorthalidone produce equivalent reductions in systolic blood pressure and potassium compared to hydrochlorothiazide in the low-dose range of 12.5-25 mg?
Population
Patients in clinical trials evaluating hydrochlorothiazide or chlorthalidone monotherapies
Comparison
Chlorthalidone monotherapy vs Hydrochlorothiazide monotherapy
Design
Meta-analysis
Authors
Loading...
Supports preferring chlorthalidone over HCTZ at low doses for SBP control; challenges equivalence assumptions and informs thiazide selection in trials.
Does chlorthalidone produce equivalent reductions in systolic blood pressure and potassium compared to hydrochlorothiazide in the low-dose range of 12.5-25 mg?
At commonly prescribed low doses (12.5-25 mg), chlorthalidone provides greater systolic blood pressure reduction than hydrochlorothiazide, suggesting they are not interchangeable.
Ernst et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: